当前位置:首页 - 行情中心 - 鹭燕医药(002788) - 财务分析 - 现金流量表

鹭燕医药

(002788)

  

流通市值:36.69亿  总市值:37.34亿
流通股本:3.82亿   总股本:3.89亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金16,996,652,201.7811,373,235,408.135,493,673,487.9622,246,773,674.99
  收到的税费返还1,464,967.681,389,764.96534,498.97524,096.6
  收到其他与经营活动有关的现金190,603,420.38107,900,409.1593,217,704.581,353,163.11
  经营活动现金流入小计17,188,720,589.8411,482,525,582.245,587,425,691.4322,328,650,934.7
  购买商品、接受劳务支付的现金15,886,079,983.0310,587,178,008.985,269,837,665.1620,556,909,627.77
  支付给职工以及为职工支付的现金438,936,783.94300,622,475.73160,828,026.67559,664,205.75
  支付的各项税费301,526,275.51205,399,123.6591,980,588.9385,405,994.85
  支付其他与经营活动有关的现金232,474,668.61178,607,983.8146,108,470.96249,187,652.79
  经营活动现金流出小计16,859,017,711.0911,271,807,592.165,668,754,751.6921,751,167,481.16
  经营活动产生的现金流量净额329,702,878.75210,717,990.08-81,329,060.26577,483,453.54
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额832,458.48751,552.3525,191.87442,908.19
  投资活动现金流入小计832,458.48751,552.3525,191.87442,908.19
  购建固定资产、无形资产和其他长期资产支付的现金185,657,832.08109,104,123.5964,271,105.09361,123,708.58
  投资支付的现金8,092,5002,092,5001,710,0008,895,000
  取得子公司及其他营业单位支付的现金---149,337.59
  支付其他与投资活动有关的现金580,071.56---
  投资活动现金流出小计194,330,403.64111,196,623.5965,981,105.09370,168,046.17
  投资活动产生的现金流量净额-193,497,945.16-110,445,071.24-65,955,913.22-369,725,137.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金618,000618,000618,0001,450,000
  其中:子公司吸收少数股东投资收到的现金618,000618,000618,0001,450,000
  取得借款收到的现金7,320,034,703.464,644,876,420.772,489,749,081.248,942,679,409.92
  收到其他与筹资活动有关的现金--3,400,000-
  筹资活动现金流入小计7,320,652,703.464,645,494,420.772,493,767,081.248,944,129,409.92
  偿还债务支付的现金7,249,516,252.134,629,035,9842,350,940,130.38,859,874,787.39
  分配股利、利润或偿付利息支付的现金264,366,607.5989,812,101.3445,239,322.58324,561,154.81
  其中:子公司支付给少数股东的股利、利润---734,561.78
  支付其他与筹资活动有关的现金49,443,092.0935,532,807.9614,871,796.7188,249,551.48
  筹资活动现金流出小计7,563,325,951.814,754,380,893.32,411,051,249.599,272,685,493.68
  筹资活动产生的现金流量净额-242,673,248.35-108,886,472.5382,715,831.65-328,556,083.76
四、汇率变动对现金及现金等价物的影响-396,890.77-187,961.55-32,045.53214,377.14
五、现金及现金等价物净增加额-106,865,205.53-8,801,515.24-64,601,187.36-120,583,391.06
  加:期初现金及现金等价物余额340,924,904.24340,924,904.24340,924,904.24461,508,295.3
  期末现金及现金等价物余额234,059,698.71332,123,389276,323,716.88340,924,904.24
补充资料:
  净利润-153,439,626.26-347,697,966.5
  资产减值准备-8,162,480.48-2,687,427.41
  固定资产和投资性房地产折旧-33,994,619.3-63,545,278.67
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,994,619.3-63,545,278.67
  无形资产摊销-2,456,876.61-5,024,785.92
  长期待摊费用摊销-5,412,776.11-11,297,323.34
  处置固定资产、无形资产和其他长期资产的损失--98,166.8--172,333.63
  固定资产报废损失-191,390.26-87,804.67
  公允价值变动损失---0
  财务费用-94,698,322.68-207,634,120.38
  投资损失-9,374,070.99-18,730,952.34
  递延所得税--2,915,996.13--9,665,685.8
  其中:递延所得税资产减少--2,758,657.49--9,397,581.56
    递延所得税负债增加--157,338.64--268,104.24
  存货的减少-294,881,254.12--292,389,396.11
  经营性应收项目的减少--297,639,539.91--400,019,113.69
  经营性应付项目的增加--121,928,689.66-560,472,106.54
  其他---0
  现金的期末余额-332,123,389-340,924,904.24
  减:现金的期初余额-340,924,904.24-461,508,295.3
  现金及现金等价物的净增加额--8,801,515.24--120,583,391.06
公告日期2025-10-272025-08-262025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑